Theratechnologies Inc.
TH.TO
TSX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.52% | 5.02% | 5.75% | 3.62% | -4.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.52% | 5.02% | 5.75% | 3.62% | -4.06% |
| Cost of Revenue | -7.81% | 4.14% | -5.18% | -4.51% | -14.49% |
| Gross Profit | 20.98% | 5.29% | 9.52% | 6.49% | 0.21% |
| SG&A Expenses | 6.91% | -1.18% | 3.22% | 0.32% | -19.61% |
| Depreciation & Amortization | -42.70% | -42.70% | -72.72% | -72.72% | -75.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.68% | -14.08% | -26.65% | -26.30% | -29.74% |
| Operating Income | 323.79% | 194.34% | 162.55% | 123.31% | 85.36% |
| Income Before Tax | 91.42% | 73.23% | 92.66% | 81.46% | 63.52% |
| Income Tax Expenses | 406.21% | 376.25% | 115.27% | -17.25% | -15.04% |
| Earnings from Continuing Operations | 79.39% | 65.33% | 89.16% | 80.53% | 63.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.39% | 65.33% | 89.16% | 80.53% | 63.01% |
| EBIT | 323.79% | 194.34% | 162.55% | 123.31% | 85.36% |
| EBITDA | 600.00% | 285.90% | 191.71% | 140.45% | 89.01% |
| EPS Basic | 87.88% | 82.47% | 92.35% | 87.57% | 69.58% |
| Normalized Basic EPS | 118.84% | 98.91% | 101.58% | 93.75% | 73.13% |
| EPS Diluted | 87.63% | 81.24% | 91.37% | 86.95% | 69.12% |
| Normalized Diluted EPS | 118.78% | 98.91% | 101.58% | 93.75% | 73.13% |
| Average Basic Shares Outstanding | 51.31% | 87.46% | 87.34% | 61.97% | 36.39% |
| Average Diluted Shares Outstanding | 52.12% | 87.47% | 87.36% | 61.98% | 36.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |